Urine test could Fine-Tune TB drug doses for better results

NCT ID NCT06318416

Recruiting now Disease control Sponsor: University of Virginia Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adjusting the dose of a key tuberculosis drug (rifampin) based on simple urine tests can help patients reach more effective drug levels in their blood. Researchers in Tanzania will enroll 200 adults and children (age 3+) with active TB to see if personalized dosing leads to better treatment outcomes. The goal is to find a practical way to optimize standard TB therapy, especially for undernourished populations where drug levels often fall short.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Haydom Lutheran Hospital
RECRUITING

Haydom, Tanzania

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

TUBERCULOSIS